The Clatterbridge Cancer Centre NHS Foundation Trust

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2026-05-13		NCT04067713
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, skin disorder, squamous cell carcinoma, triple-negative breast carcinoma, urinary system disorder	Recruiting	Phase 1 / Phase 2	2025-09-17		NCT05329532

Clinical trials